To date, reports of the detection rate for a mutation in ENG and ACVRL1 in HHT have come from laboratories, which receive samples from clinicians with a wide range of expertise with regards to recognizing clinical manifestations of HHT (Richards-Yutz et al., 2010; McDonald et al., 2011b). Here, ENG is linked to hereditary hemorrhagic telangiectasia.